| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241618 A polynucleotide comprising a RNA polymerase promoter, able encoding a siRNA; treating cancer and genetic disorders; genetic engineering, inhibit gene expression of a target gene |
| 07/10/2007 | US7241617 Transferring nucleic acids into nerve cells; mix cell and vector, incubate, recover transformed nerve cells |
| 07/10/2007 | US7241591 Adenovirus comprising a gene coding for glutathione peroxidase |
| 07/10/2007 | US7241450 DNA sequence and recombinant production of a Gramineae allergen |
| 07/10/2007 | US7241440 Identifying a subject in need of an increase in titer of IgG antibodies that are specific for a viral antigen; providing an immunogenic composition comprising ribavirin and a nucleic acid molecule encoding viral antigen. |
| 07/10/2007 | CA2260756C System for genetically treating cardiac conduction disturbances |
| 07/10/2007 | CA2200371C Human npik gene |
| 07/10/2007 | CA2124769C Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/10/2007 | CA2098849C Control of gene expression by ionizing radiation |
| 07/10/2007 | CA2087818C Oligonucleotide analogs, their preparation and use |
| 07/05/2007 | WO2007076548A2 RNAi-MEDIATED INHIBITION OF IGFlR FOR TREATMENT OF OCULAR ANGIOGENESIS |
| 07/05/2007 | WO2007076537A2 Methods and compositions related to mutant kunitz domain i of tfpi-2 |
| 07/05/2007 | WO2007076454A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 07/05/2007 | WO2007076366A2 Double stranded nucleic acid molecules targeted to il-4 receptor alpha |
| 07/05/2007 | WO2007076319A2 Human glp-1 mimetibodies and compositions for treating obesity and related disorders, methods and uses |
| 07/05/2007 | WO2007076101A2 Immunologically enhanced recombinant vaccines |
| 07/05/2007 | WO2007075845A2 Isolated mcpip and methods of use |
| 07/05/2007 | WO2007075655A2 Compositions and methods for altering rnai |
| 07/05/2007 | WO2007075626A2 Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo tm) contiaining different lengths of palindromic segments |
| 07/05/2007 | WO2007075371A2 Protein modulators of resistance to alkylating agents |
| 07/05/2007 | WO2007075308A2 Vaccine candidates against johne's disease |
| 07/05/2007 | WO2007075206A2 Satb1: a determinant of morphogenesis and tumor metastatis |
| 07/05/2007 | WO2007074707A1 THERAPEUTIC AGENT FOR NEUROBLASTOMA TARGETING ARID3b |
| 07/05/2007 | WO2007073768A1 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 07/05/2007 | WO2007051267A3 Method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions |
| 07/05/2007 | WO2007050102A9 Dendritic cell based vaccines |
| 07/05/2007 | WO2007036028A9 Compositions for and methods of granzyme b inhibition |
| 07/05/2007 | WO2007002512A3 Neuroprotective effective compound |
| 07/05/2007 | WO2006033669A3 Method of modulating vascularization |
| 07/05/2007 | WO2004083381A3 Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants |
| 07/05/2007 | US20070157328 Suppression of xenotransplant rejection |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070157050 Process for providing submodel performance in a computer processing unit |
| 07/05/2007 | US20070155691 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression |
| 07/05/2007 | US20070155690 RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis |
| 07/05/2007 | US20070155689 Methods of regulating growth and death of cancer cells |
| 07/05/2007 | US20070155688 Recombinant plasmid vector; nucleic acid sequence encoding a BMP-7 polypeptide operatively linked to a promoter; IGF-1 signal sequence, tPA signal sequence; signal peptide encoded by a nucleotide sequence; hemodynamic-based plasmid DNA gene delivery; delivery of naked plasmid; occlusion balloon catheter |
| 07/05/2007 | US20070155687 Methods and compositions for altering cell function |
| 07/05/2007 | US20070155686 RNAi modulation of HIF-1 and therapeutic uses thereof |
| 07/05/2007 | US20070155685 Pharmaceutical composition |
| 07/05/2007 | US20070155684 Compositions and methods for generating short double-stranded rna using mutated rnase III |
| 07/05/2007 | US20070155683 Containing a single-stranded oligonucleotide DNA molecule containing one or more CpG(s); SARS virus, hepatitis C virus, dengue virus and Japanese encephalitis, influenza virus |
| 07/05/2007 | US20070155682 Translational control by small, non-translatable rnas |
| 07/05/2007 | US20070155662 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a) |
| 07/05/2007 | US20070155658 Complexed via melamine derivative and optionally polyarginine or a polymer of glutamine and asparagine; RNA interference |
| 07/05/2007 | US20070155008 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation |
| 07/05/2007 | US20070154991 Transgenic bacillus for use as bioreactor in production of capsular polysaccharide A |
| 07/05/2007 | US20070154986 Streptococcus pneumoniae Polynucleotides and Sequences |
| 07/05/2007 | US20070154918 44 Human Secreted Proteins |
| 07/05/2007 | US20070154916 Method for detecting cancer and a method for suppressing cancer |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154910 50 Human Secreted Proteins |
| 07/05/2007 | US20070154908 Connective Tissue Growth Factor-2 |
| 07/05/2007 | US20070154905 Modulators of the function of fas receptors and other proteins |
| 07/05/2007 | US20070154901 Comprising tetranectin trimerising structural element (TTSE) capable of forming a stable complex with two other TTSEs; stability; used as a carrier of other chemical entities; drug delivery |
| 07/05/2007 | US20070154529 Uses of dna binding proteins |
| 07/05/2007 | US20070154517 Methods and devices for promoting endothelial morphogenesis |
| 07/05/2007 | US20070154488 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/05/2007 | US20070154487 Compositions and methods for modulation of RORgammat functions |
| 07/05/2007 | US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 07/05/2007 | US20070154485 Anticancer agents using verotoxin variants |
| 07/05/2007 | US20070154467 Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
| 07/05/2007 | US20070154465 Stem cell therapy for retinal disease |
| 07/05/2007 | US20070154464 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell |
| 07/05/2007 | US20070154458 Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
| 07/05/2007 | US20070154457 Use of eIF-5A to kill multiple myeloma cells |
| 07/05/2007 | US20070154456 Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression |
| 07/05/2007 | US20070154455 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 07/05/2007 | US20070154451 Enhancer contains interleukin as an effective component and is co-administered with a recombinant herpes simplex virus that selectively replicates in cancer cells |
| 07/05/2007 | US20070154450 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 07/05/2007 | US20070154447 Linear polyethylenimine-sterol conjugates for gene delivery |
| 07/05/2007 | CA2655993A1 Satb1: a determinant of morphogenesis and tumor metastatis |
| 07/05/2007 | CA2641828A1 Isolated mcpip and methods of use |
| 07/05/2007 | CA2635726A1 Methods and compositions related to mutant kunitz domain i of tfpi-2 |
| 07/05/2007 | CA2635375A1 Synergistic effect between a cyanogenic system and another oxidative inducer for the treatment of tumours |
| 07/05/2007 | CA2634784A1 Human glp-1 mimetibodies and compositions for treating obesity and related disorders, methods and uses |
| 07/05/2007 | CA2634480A1 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 07/05/2007 | CA2632940A1 Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo tm) contiaining different lengths of palindromic segments |
| 07/04/2007 | EP1804062A2 YKL-40 as a marker and prognostic indicator for cancers |
| 07/04/2007 | EP1803811A1 Chimeric (double) decoy |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1802656A1 Tweak receptor |
| 07/04/2007 | EP1802653A2 Mam domain containing protein |
| 07/04/2007 | EP1802643A1 Antiviral oligonucleotides |
| 07/04/2007 | EP1802351A2 Disimmortalizable mammalian chromaffin cell lines for cell therapy for pain |
| 07/04/2007 | EP1619949A4 Postnatal stem cells and uses thereof |
| 07/04/2007 | EP1503716A4 System and method for treating cardiac arrhythmias with fibroblast cells |
| 07/04/2007 | EP1311699B1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 07/04/2007 | EP1257658B1 Method for increasing the gene expression of transfected genes |
| 07/04/2007 | EP1194560B1 Antigenic neisserial peptides |
| 07/04/2007 | EP1082011B1 Avian polyomavirus vaccines in psittacine birds |
| 07/04/2007 | EP1053023B1 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 07/04/2007 | EP1034301B1 Inhibition of an fgf-binding protein using ribozymes |
| 07/04/2007 | EP0868435B1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 07/04/2007 | CN1993463A Follistatin mutant polypeptide |
| 07/04/2007 | CN1993136A Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/04/2007 | CN1990865A Method of treating endotoxemia |
| 07/04/2007 | CN1990523A Preparing method of shell crosslinked polymers micelle, drug and gene vector thereof |